SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast

Timothy M Piazza1, Juu-Chin Lu, Kristopher C Carver

  • 1Department of Comparative Biosciences, University of Wisconsin, Madison, Wisconsin 53706, USA.

Insights

Prolactin (PRL) down-regulates its long receptor (lPRLR) in breast cancer cells via src family kinases (SFKs) and dynamin-2-mediated endocytosis, selectively impacting ERK1/2 and Akt signaling.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Endocrinology

Background:

  • Prolactin (PRL) plays a role in human breast cancer, but its regulation of its own receptor (PRLR) is poorly understood.
  • Ligand-initiated endocytosis is crucial for receptor regulation and signaling, potentially contributing to oncogenesis.
  • Exogenous PRL accelerates long PRL receptor (lPRLR) degradation, but the underlying signals and downstream pathways in breast cancer cells remain unclear.

Purpose of the Study:

  • To elucidate the signaling pathways and mechanisms by which prolactin (PRL) induces the internalization and down-regulation of its long receptor (lPRLR) in breast cancer cells.
  • To investigate the role of src family kinases (SFKs) and endocytosis in PRL-induced lPRLR regulation and downstream signaling.

Main Methods:

  • Utilized MCF-7 breast cancer cells.
  • Investigated the effect of src family kinases (SFKs) and Janus kinase 2 inhibition on PRL-induced lPRLR down-regulation.
  • Examined the association of lPRLR with SFKs in lipid rafts.
  • Assessed the role of dynamin-2 and endocytosis in lPRLR internalization and signaling.
  • Analyzed the phosphorylation of downstream signaling molecules like ERK1/2, Akt, Janus kinase 2, and signal transducer and activator of transcription 5.

Main Results:

  • PRL-induced lPRLR down-regulation was significantly reduced by SFK inhibition, but not by Janus kinase 2 inhibition.
  • SFK inhibition led to the accumulation of a PRLR extracellular domain fragment, suggesting involvement in newly synthesized receptor processing.
  • lPRLR constitutively associated with SFKs within lipid rafts.
  • PRL-induced SFK activation promoted dynamin-2 recruitment, leading to lPRLR endocytosis, which was essential for its down-regulation.
  • Endocytosis was required for optimal phosphorylation of ERK1/2 and Akt, but not for Janus kinase 2 or signal transducer and activator of transcription 5.

Conclusions:

  • Src family kinases (SFKs) are critical mediators of prolactin (PRL)-initiated lPRLR internalization and down-regulation in breast cancer cells.
  • Ligand-induced endocytosis of lPRLR is essential for modulating specific downstream signaling pathways, including ERK1/2 and Akt.
  • These findings highlight the importance of SFKs and receptor trafficking in PRL signaling within the context of breast cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Cell Signaling in Plants01:25

Cell Signaling in Plants

Plant cells communicate to coordinate their cycle of growth, flowering and fruiting, and activities in roots, shoots, and leaves in response to the changing environmental conditions. Plant signaling is distinct from animal signaling. Plants primarily utilize enzyme-linked receptors, whereas the largest class of cell-surface receptors in animals are G-protein coupled receptors (GPCRs). Unlike animals, receptor tyrosine kinases are rare in plants. Instead, plants have a diverse class of...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...